These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 554820)

  • 21. [Retrospective study on a possible ototoxicity of tobramycin in the newborn infant].
    Giaccai F; Bigozzi M; Salimbeni C; Periti P
    Clin Ter; 1975 Dec; 75(5):479-89. PubMed ID: 1218464
    [No Abstract]   [Full Text] [Related]  

  • 22. Cross-sensitivity within the neomycin group of antibiotics.
    Förström L; Pirilä V; Pirilä L
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):67-9. PubMed ID: 160737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ototoxicity and nephrotoxicity of gentamicin and tobramycin].
    Andreu J; Bodet B; Garand G; Dabo B; Leroy G
    Cah Anesthesiol; 1985 Oct; 33(6):515-21. PubMed ID: 4084845
    [No Abstract]   [Full Text] [Related]  

  • 24. [Vestibular tests in infants after treatment with aminoglycosides].
    Zagólski O
    Pol Merkur Lekarski; 2005 Nov; 19(113):638-41. PubMed ID: 16498801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kanendomycin in respiratory tract infection. Comparative clinical study of other aminoglycosides].
    Ginesu F; Ortu AR; Puddu E; Schena G
    G Ital Chemioter; 1980; 27(2):69-80. PubMed ID: 7341329
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ototoxicity and nephrotoxicity of netilmicin and other aminoglycoside antibiotics in rabbits].
    Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
    Nihon Jibiinkoka Gakkai Kaiho; 1982 Apr; 85(4):447-54. PubMed ID: 7119929
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk factors for toxicity in elderly patients given aminoglycosides once daily.
    Paterson DL; Robson JM; Wagener MM
    J Gen Intern Med; 1998 Nov; 13(11):735-9. PubMed ID: 9824518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tobramycin nephrotoxicity. A prospective clinical study.
    Coca A; Blade J; Martinez A; Segura F; Soriano E; Ribas-Mundo M
    Postgrad Med J; 1979 Nov; 55(649):791-6. PubMed ID: 523366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study.
    Kumin GD
    JAMA; 1980 Oct; 244(16):1808-10. PubMed ID: 7420681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative cost effectiveness of gentamicin and tobramycin.
    Holloway JJ; Smith CR; Moore RD; Feroli ER; Lietman PS
    Ann Intern Med; 1984 Dec; 101(6):764-9. PubMed ID: 6437310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nephrotoxicity of gentamycin and tobramycin combined with methicillin or cephalothin].
    Lietman PS
    Nouv Presse Med; 1978 Nov; 7(42):3833-4. PubMed ID: 714687
    [No Abstract]   [Full Text] [Related]  

  • 32. Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs.
    Reiner NE; Bloxham DD; Thompson WL
    J Antimicrob Chemother; 1978 May; 4 Suppl A():85-101. PubMed ID: 659354
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
    Weippl G
    Clin Ther; 1983; 5(4):342-7. PubMed ID: 6347380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.
    de Jager P; van Altena R
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):622-7. PubMed ID: 12102302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Urine chemiluminescence in preclinical diagnosis of neonatal drug-induced nephropathy].
    Panova LD; Farkhutdinov RR; Akhmadeeva EN
    Urol Nefrol (Mosk); 1998; (4):25-9. PubMed ID: 9727317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tubulointerstitial nephropathies due to antibiotics].
    Fillastre JP
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):428-39. PubMed ID: 4374559
    [No Abstract]   [Full Text] [Related]  

  • 37. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.
    Prins JM; Weverling GJ; de Blok K; van Ketel RJ; Speelman P
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2494-9. PubMed ID: 8913452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial pharmacokinetic dosing of aminoglycosides: a community hospital experience.
    Hoffa DE
    Ther Drug Monit; 1989 Sep; 11(5):574-9. PubMed ID: 2815234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.
    Schentag JJ; Plaut ME; Cerra FB
    Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The predictive value of urinary N-acetyl-beta-D-glucosaminidase in evaluating aminoglycoside nephrotoxicity.
    Guh JY; Su YH; Chen HJ; Tsai JH
    Taiwan Yi Xue Hui Za Zhi; 1985 Oct; 84(10):1099-107. PubMed ID: 3866825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.